This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity | MicrobiomeTrials

NCT00092222

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2004-10-28Est. Completion: 2026-10-01

Enrollment target: 75 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Multiple Myeloma (MM)Multiple Myeloma RefractoryMultiple Myeloma in RelapseMultiple Myeloma

This is a Phase II, open-label, nonrandomized, single-arm study of elranatamab that will be administered in the outpatie…

Multiple LocationsEst. completion Oct 2029

Mantle Cell Lymphoma

The proposed study is an open-label, single arm phase II study of venetoclax in combination with rituximab in patients o…

Baltimore, United StatesCompleted May 14, 2025

B-AllAcute Lymphoblastic Leukemia

Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat peopl…

Los Angeles, United StatesEst. completion Dec 31, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.